Moolec Science (MLEC) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Moolec Science reports a robust third quarter for FY 2024 with key achievements including USDA-APHIS approval for their Piggy Sooy™ soybean product and the successful progression of their GLASO™ safflower planting campaign. Financially, the company saw an increase in normalized revenues by roughly $1.3 million year-over-year, although operational costs also rose, reflecting a strategic investment in their soy-protein ingredient business and research and development efforts. These milestones underscore Moolec’s commitment to sustainable and nutritional innovation in the food ingredient sector.
For further insights into MLEC stock, check out TipRanks’ Stock Analysis page.
